triolmesar forte 5 tablet, film-coated
macleods pharmaceuticals limited, india - olmesartan, amlodipine , hydrochlorothiazide - tablet, film-coated - 40 + 12.5 + 5 mg
triolmesar tablet, film-coated
macleods pharmaceuticals limited, india - olmesartan, amlodipine , hydrochlorothiazide - tablet, film-coated - 20 + 12.5 + 5 mg
carbimazole macleods tablet
macleods pharmaceuticals ltd., india - carbimazole - tablet - 5 mg
dolutegravir sodium
macleods pharmaceuticals limited - dolutegravir sodium - tablet, coated; oral - 10mg
dbl bleomycin 15000 iu powder for injection
pfizer australia pty ltd - bleomycin sulfate, quantity: 15000 iu - injection, powder for - excipient ingredients: - bleomycin is used for palliation and/or treatment adjuvant to surgery and radiation therapy and in the management of the following neoplasms: squamous cell carcinoma of the skin, head and neck, and oesophagus is the primary indication for bleomycin. tumour response has been obained in a number of patients with squamous cell carcinoma of the penis, larynx and uterine cervix. infrequent response has been shown in squamous cell carcinoma of the bronchus. treatment of choriocarcinoma and embryonal cell carcinoma of the testis is also indicated. bleomycin has been effectively used in advanced hodgkin's disease and in some cases of other lymphomas such as non-hodgkin's, and also in cases of mycosis fungoides.
fucicort
leo pharma limited - betamethasone valerate 0.1%{relative} (expressed as betamethasone); ; fusidic acid 2%{relative} (hemihydrate, expressed as anhydrous fusidic acid); - topical cream - active: betamethasone valerate 0.1%{relative} (expressed as betamethasone) fusidic acid 2%{relative} (hemihydrate, expressed as anhydrous fusidic acid) excipient: cetomacrogol 1000 cetostearyl alcohol chlorocresol liquid paraffin monobasic sodium phosphate dihydrate purified water sodium hydroxide white soft paraffin
propylthiouracil 50mg tablets
macleods pharma uk ltd - propylthiouracil - oral tablet - 50mg
metformin hydrochloride tablet, film coated
macleods pharmaceuticals limited - metformin hydrochloride (unii: 786z46389e) (metformin - unii:9100l32l2n) - metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 2 diabetes mellitus. metformin hydrochloride tablets are contraindicated in patients with: • severe renal impairment (egfr below 30 ml/min/1.73 m2 ) (see warnings and precautions ). • known hypersensitivity to metformin hydrochloride. • acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. diabetic ketoacidosis should be treated with insulin.
pyrazinamide tablet
macleods pharmaceuticals limited - pyrazinamide (unii: 2kni5n06ti) (pyrazinamide - unii:2kni5n06ti) - pyrazinamide is indicated for the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents. (the current recommendation of the cdc for drug- susceptible disease is to use a six-month regimen for initial treatment of active tuberculosis, consisting of isoniazid, rifampin and pyrazinamide given for 2 months, followed by isoniazid and rifampin for 4 months.* 4 ) (patients with drug-resistant disease should be treated with regimens individualized to their situation. pyrazinamide frequently will be an important component of such therapy.) (in patients with concomitant hiv infection, the physician should be aware of current recommendation of cdc. it is possible these patients may require a longer course of treatment). it is also indicated after treatment failure with other primary drugs in any form of active tuberculosis. pyrazinamide should only be used in conjunction with other effective antituberculous agents. *see recommendations of center for disease cont
tolterodine tartrate tablet, film coated
macleods pharmaceuticals limited - tolterodine tartrate (unii: 5t619tqr3r) (tolterodine - unii:whe7a56u7k) - tolterodine tartrate 1 mg - tolterodine tartrate tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. tolterodine tartrate tablets are contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. tolterodine tartrate is also contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients, or to fesoterodine fumarate extended-release tablets which, like tolterodine tartrate, are metabolized to 5-hydroxymethyl tolterodine.